There is a level of transparency every patient should expect when considering a form of regenerative therapy, where a physician not only understands the power of what regenerative medicine is capable of but also doesn’t dismiss its current limitations. Whether you’re considering stem cells, exosomes, or platelet-rich plasma, science has a lot of catching up to do. Yet with billions on the table, the industry isn’t slowing down to find out.
The global regenerative medicine market is projected to grow from $58.40 billion this year to $360.84 billion by 2034, according to industry predictions. More than 1,500 businesses promote stem cell…
Read the full article at MUSCLEANDFITNESS.COM